PDF-Cystatin C

K ASSAY 1 Rev 202 2 0 7 0 7 KAMIYA BIOMEDICAL COMPANY K ASSAY Cystatin C For the Quantitative Deter mination of Human Cystatin C in Serum or Plasma Cat No KAI 074 INTENDED USE F. Kevin Harley, M.D.. Assistant Clinical Professor. Department of Medicine. Division of Nephrology & Hypertension. UC Irvine Medical Center. Objectives. Review Definition of CKD and its classification. Disease. NGAL and Cystatin C. COL SOHAIL SABIR. HOD NEPHROLOGY MILITARY HOSPITAL. HOD MEDICAL EDUCATION . ARMED . FORCES POSTGRADUATE MEDICAL INSTITUTE. Biomarker. characteristic . that is objectively measured and evaluated as an indicator of normal biological or pathogenic processes, or pharmacologic responses to a therapeutic intervention. Definition of CKD. Staging of CKD. Etiology of CKD. How to measure Kidney function . Incidence of ESRD. (per million population, 1990, by HSA, unadjusted). USRDS, 2000. Incidence of ESRD. (per million population, 2000, by HSA, unadjusted) . Analytical study of three cystatin C assays and their impact on cystatin C- based GFR-prediction equations Pierre Delanaye, Laurence Pieroni, Christelle Abshoff, Laurence Lutteri, Jean-Paul Chapelle, which is directly traceable to ERM-DA471/IFCC, the international standard reference material. The test utilizes Avian IGY antibodies to virtually eliminate some of the most common causes for interfe 5 5 DOI: 10.7860/JCDR/2018/36574.12203 Original Article Miscellaneous Postgraduate Education Letter to Editor Short Communication Images in Medicine Experimental Research Clinician’s corner Revie